351 related articles for article (PubMed ID: 22736090)
1. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
[TBL] [Abstract][Full Text] [Related]
2. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
Maria NI; Brkic Z; Waris M; van Helden-Meeuwsen CG; Heezen K; van de Merwe JP; van Daele PL; Dalm VA; Drexhage HA; Versnel MA
Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963
[TBL] [Abstract][Full Text] [Related]
3. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
[TBL] [Abstract][Full Text] [Related]
5. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
6. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
Front Immunol; 2021; 12():701656. PubMed ID: 34413853
[TBL] [Abstract][Full Text] [Related]
7. The Expression of BAFF Is Controlled by IRF Transcription Factors.
Sjöstrand M; Johansson A; Aqrawi L; Olsson T; Wahren-Herlenius M; Espinosa A
J Immunol; 2016 Jan; 196(1):91-6. PubMed ID: 26590315
[TBL] [Abstract][Full Text] [Related]
8. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
9. Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren's syndrome.
Björk A; Richardsdotter Andersson E; Imgenberg-Kreuz J; Thorlacius GE; Mofors J; Syvänen AC; Kvarnström M; Nordmark G; Wahren-Herlenius M
RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958277
[TBL] [Abstract][Full Text] [Related]
10. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
11. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells.
Wildenberg ME; van Helden-Meeuwsen CG; van de Merwe JP; Drexhage HA; Versnel MA
Eur J Immunol; 2008 Jul; 38(7):2024-33. PubMed ID: 18581327
[TBL] [Abstract][Full Text] [Related]
12. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Huijser E; Bodewes ILA; Lourens MS; van Helden-Meeuwsen CG; van den Bosch TPP; Grashof DGB; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Brkic Z; Dik WA; Versnel MA
Rheumatology (Oxford); 2022 Aug; 61(8):3491-3496. PubMed ID: 35022662
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation-Based Interferon Scores Associate With Sub-Phenotypes in Primary Sjögren's Syndrome.
Imgenberg-Kreuz J; Sandling JK; Norheim KB; Johnsen SJA; Omdal R; Syvänen AC; Svenungsson E; Rönnblom L; Eloranta ML; Nordmark G
Front Immunol; 2021; 12():702037. PubMed ID: 34335613
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
15. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
[TBL] [Abstract][Full Text] [Related]
16. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
[TBL] [Abstract][Full Text] [Related]
17. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome.
Yoshimoto K; Tanaka M; Kojima M; Setoyama Y; Kameda H; Suzuki K; Tsuzaka K; Ogawa Y; Tsubota K; Abe T; Takeuchi T
Arthritis Res Ther; 2011; 13(5):R170. PubMed ID: 22018243
[TBL] [Abstract][Full Text] [Related]
18. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
[TBL] [Abstract][Full Text] [Related]
20. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E
Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
